Please login to the form below

Not currently logged in
Email:
Password:

AI drug discovery

This page shows the latest AI drug discovery news and features for those working in and with pharma, biotech and healthcare.

Policy and public health: ML and AI in healthcare

Policy and public health: ML and AI in healthcare

With these facts in hand, the motivation for machine learning (ML) and artificial intelligence (AI) to address the issues of drug discovery speed, cost and lead candidate identification holds tremendous promise. ... The cost and time involved with

Latest news

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • AI and accelerated computing ring in new era for healthcare AI and accelerated computing ring in new era for healthcare

    How AI can reduce drug discovery timelines. Today, we can produce more biomedical data in about three months than the entire 300-year history of healthcare. ... Application frameworks bridge this gap by providing researchers and clinicians the tools for

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    Novartis is investing in artificial intelligence, in alliance with Microsoft, to improve processes, drug design and manufacturing. ... Big data and healthcare. Switzerland is also home to all the major IT companies and both pharma and biotechs are

  • Has AI been the key to tackling the COVID-19 pandemic? Has AI been the key to tackling the COVID-19 pandemic?

    attributes of the drug, they can also uncover whether drugs previously used for other treatments could be an effective cure for this virus. ... UK-based BenevolentAI is just one such company that has used AI and machine learning to aid drug discovery.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Drug discovery. AI has the potential to significantly reduce the costs and time associated with drug discovery, across medical divisions and also specifically in handling the immediate COVID threat. ... achieve. Insilico Medicine was able to do this

  • A snapshot of… Exscientia A snapshot of… Exscientia

    As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our world-class scientists. ... However, another key business challenge in the AI drug discovery field is

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics